| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |